AcelRx is a California-based specialty pharmaceutical company that develops and commercializes innovative therapies for the treatment of acute pain.
Business Model:
Revenue: $1.5M
Employees: 11-50
Address: 25821 Industrial Boulevard
City: Hayward
State: CA
Zip: 94545
Country: US
AcelRx is a California-based specialty pharmaceutical company that develops and commercializes innovative therapies for the treatment of acute pain.
Contact Phone:
+16502163500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/18/2011
IPO Valuation:
$95M
Ticker Symbol:
ACRX
IPO Price:
$5/share
Amount Raised:
$40M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2015 | Encycle Therapeutics | Venture Round | 0 |
9/2015 | Encycle Therapeutics | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2012 | Post-IPO Equity | $10M | 9/2010 | Debt Financing | $8M | 11/2009 | Venture Round | $14.8M | 8/2022 | Post-IPO Equity | $630k | 7/2011 | Post-IPO Debt | $20.8M | 1/2022 | Post-IPO Equity | $5.2M | 1/2021 | Post-IPO Equity | $27.5M | 6/2012 | Post-IPO Equity | $10M | 12/2022 | Post-IPO Equity | $7.5M | 6/2019 | Post-IPO Debt | 1 | $25M |
Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC Oxford Finance LLC |
12/2013 | Post-IPO Debt | 1 | $40M |
Hercules Capital Hercules Capital |
11/2021 | Post-IPO Equity | $14M |
---|
Announced Date | Name | Price |
---|---|---|
11/2021 | Lowell Therapeutics | |
3/2020 | Tetraphase Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|